Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Lymphoma Diagnosis and Treatment, and Immune Cell Function and Interaction.
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer
PD-1<sup>+</sup>CXCR5<sup>−</sup>CD4<sup>+</sup> Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
<scp>WWC</scp>2 is an independent prognostic factor and prevents invasion <i>via</i> Hippo signalling in hepatocellular carcinoma
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling
Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer
Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
PubMed 2015cited by 99position: middle
Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma